The organization of the insulin gene ofthe owl or night monkey (Aotus tivirgatus), a New World primate, is similar to that of the human gene. The sequences of these two genes and flanking regions possess 84.3% hoanology. An
unusual feature of the owl monkey gene is the partial duplication and insertion of a portion of the A-chain coding sequence into the 3' untranslated region. The insulin gene of this primate also lacks a region of tandem repeats that is present in the 5' flanking region of the human and chimpanzee genes. Owl monkey preproinsulin has 85.5% identity with the human insulin precursor and is the most divergent of the primate insulins/preproinsulins yet described. The differences between owl monkey and human preproinsulin include three substitutions in the signal peptide, two in the B chain, seven in the C peptide, and three in the A chain. One of these replacements is the conservative substitution of valine for isoleucine at position A2, an invariant site in all other vertebrate insulins and insulin-like growth factors. The substitutions in owl monkey insulin at B9, B27, A2, A4, and A17 alter its structure so that it has only 20% of the receptor-binding activity and 1% of the affinity with guinea pig anti-porcine insulin antibodies as compared to human insulin.
The sequences of mammalian insulins are in general highly conserved, differing at only one to four positions and having 92-98% identity (1) . Thus, polyclonal antibodies raised against bovine or porcine insulin usually bind insulins of other mammals with only small variations in cross-affinity (2) . However, the insulins of some hystricomorph rodents (3) and New World monkeys (4) do not cross-react significantly with these antibodies. The sequences of the insulins from several New World hystricomorphs (guinea pig, coypu, casiragua, cuis, chinchilla) and one Old World species (African porcupine) have revealed that they are, in general, highly divergent, having accumulated 7-22 amino acid replacements and possessing only 57-86% identity with the human hormone (5, 6) . These insulins also exhibit other unusual physical and biological properties in addition to their poor cross-reactivity with anti-bovine/porcine insulin serum (cuis and chinchilla insulin can be neutralized by this antisera, indicating that not all hystricomorph rodents possess insulins whose antigenic structure differs from other mammals). They do not self-associate to form dimers or, in the presence of zinc, hexamers (7) (8) (9) (10) . They also exhibit reduced insulin receptor-binding affinity and low metabolic potency (11) but have enhanced in vitro growth-promoting effects (12) . The molecular basis for the low cross-reactivity of New World monkey insulins with anti-porcine insulin antibodies has not been examined further since the report of Mann and Crofford in 1970 (4) (13) . Phage containing the owl monkey insulin gene were identified by cross-hybridization with the insert from the human insulin gene plasmid phins96 (14) .
Subfragments of the 12-kbp owl monkey EcoRI fragment containing various parts of the insulin gene were subcloned into M13 mplO (15) and sequenced by the dideoxy chaintermination method (16) . The sequence of the 5' flanking region of the gene, exons 1-3, and intron A was determined on both strands as was about 75% of the sequence of intron B. The nucleotide sequence was read against and compared with that of the human insulin gene to confirm that differences were not due to sequencing or clerical errors. Purification and Crystallization of Owl Monkey Insulin. Insulin was purified from three pancreases (1.6 g wet weight) obtained at autopsy. The tissue was homogenized in ice-cold acid/ethanol and the insulin was partially purified from this extract by isoelectric precipitation and gel filtration on a 1.0 x 50 cm Bio-Gel P-30 column (Bio-Rad) with 3 M acetic acid as the eluant (17) . Fractions containing insulin, identified by their position of elution, were pooled and concentrated. The insulin in this material was purified to homogeneity by HPLC (18) . Zinc insulin crystals were prepared using standard procedures (19) .
Insulin and Radioreceptor Assays. Immunoassays were performed as described elsewhere (20) using a guinea pig anti-porcine insulin antibody prepared in this laboratory and anti-human C-peptide antibody M1230. Receptor-binding potency was measured in a displacement assay using IM-9 cells and 1251-labeled human insulin.
Abbreviation: HVR, hypervariable region. *The sequence reported in this paper is being deposited in the EMBL/GenBank data base (Bolt, Beranek, and Newman Laboratories, Cambridge, MA, and Eur. Mol. Biol. Lab., Heidelberg) (accession no. J02989).
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Southern blot of the owl monkey insulin gene. Five micrograms of DNA was digested with EcoRI and after agarose gel electrophoresis was transferred to a nitrocellulose filter that was hybridized with the nick-translated insert from the human insulin plasmid phins96 using standard conditions. The size of the hybridizing fragment is indicated.
RESULTS
The human insulin gene probe hybridizes to a single EcoRI fragment of about 12 kbp in a digest of owl monkey DNA ( (Fig. 2) . The boundaries of the exons were assigned by comparison with the human insulin gene sequence (22, 23) . The overall nucleotide sequence homology between the owl monkey and human sequences is 84.3% (insertions/deletions were counted as one difference regardless of size): upstream of the hypervariable region (HVR), 78.8%; between the HVR and exon 1, 90.7%; exon 1, 75.6%; intron A, 84.9%; exon 2, 91.2%; intron B, 82.6%; exon 3, 82.9%; and 3' flanking, 79.1%. There is 85.5% identity between the amino acid sequences of owl monkey and human preproinsulin (Fig. 3 ) and 89.9% nucleotide sequence homology between the protein-coding regions of these two genes.
Owl monkey insulin was purified to homogeneity using a simple three-step procedure starting with 1.6 g of tissue. The final recovery, about 175 gg, is in the range expected. The purified material behaved as a single component on HPLC with a retention time about 3 min longer than human insulin, which is consistent with the differences in the sequences of the owl monkey and human proteins. Owl monkey insulin readily crystallized in the presence of Zn ions at pH 6.1 and, on microscopy, the crystals resembled square-based bipyramids of regular octahedral form, implying 4-3-2 symmetry of a cubic space group (Fig. 4) .
The purified owl monkey insulin was only 20% as efficient as human insulin in displacing 125I-labeled human insulin binding to IM-9 cells (Fig. 5 ). This suggests that the metabolic potency of owl monkey insulin is about 20% that ofthe human hormone. The owl monkey insulin bound to anti-porcine insulin antibodies about 1% as well as human insulin (Fig. 5 
MACAQ----------
HUMAN Arg Arg Glu Ala Glu Asp Leu Gln Val Gly Gln Val Glu Leu Gly Gly Gly Pro Gly Ala Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg (5) and Watt (25) . The human, chimpanzee, African green monkey, and owl monkey sequences are from Bell et al. (22) , this publication, and our unpublished observations. of two nonallelic molecules of slightly different sequence (1), cross-reacted with these antibodies about 50% as well as human insulin.
We also attempted to measure insulin and C peptide in the sera of three owl monkeys before and after a meal using standard clinical radioimmunoassay procedures. However we were unable to detect either insulin or C peptide.
DISCUSSION
The organization of the owl monkey insulin gene is similar to that of the human insulin gene (22, 23) . However, there are FIG. 4 . Crystals of owl monkey insulin. (x250.) notable differences. First, the 5' flanking region of the owl monkey sequence lacks a region of tandem repeats analogous to the HVR of the human gene (26) and instead has a sequence-GCAGGGGTCTGGGG-that is closely related to the consensus repeat-ACAGGGGTGTGGGGG-of the human HVR. The insulin gene of an Old World monkey, the African green monkey (Cercopithecus aethiops) (S.S. and G.I.B., unpublished data) also lacks a HVR-like region and has in its place a sequence, ACAGGGTCCCAGG ACAG-GGGGTCTGGGG, that is homologous to two copies of the consensus repeat found in the human insulin gene HVR. There is a region of 21 repeats of the consensus sequence ACAGGGGTCCTGGGG flanking the chimpanzee insulin gene (S.S. and G.I.B., unpublished data). Thus, this region of tandem repeats, which in the human constitutes the polymorphic HVR (14, 26) , appears to have arisen during evolution of the higher apes. The reasons for the tandem duplication of a sequence in this region are unknown. Second, the part of the owl monkey gene encoding the 3' untranslated region of the mRNA is much longer than the cognate region of the human gene due to the insertion of an 89-bp segment following the TAG stop codon (Fig. 2) . This 89-bp "insert" contains a 43-bp segment (underlined in Fig. 2 ) that is an imperfect direct duplication-there are four mismatches-of part of the region encoding the A chain of owl monkey insulin. Similar partial duplications of the protein-coding region of the insulin gene have not been observed in other vertebrates. The extent to which this 43-bp duplication or even duplications of other regions of the owl monkey gene, which were subsequently lost, facilitated the accumulation of the large number ofamino acid replacements described below is unknown.
The predicted amino acid sequence of owl monkey insulin (Figs. 2 and 3) is not identical to any vertebrate or primate insulin yet characterized (1). Its sequence differs at five positions from that of human insulin having substitutions at residues B9, B27, A2, A4, and A17. By contrast, the sequences of insulins from the chimpanzee and two Old World monkeys, the cynomolgus monkey (Macaca fascicularis) (24) and African green monkey, are identical to human (Fig. 3) . The sequence of owl monkey preproinsulin is thus the most divergent of the known primate sequences. The COOH-terminal half of the C peptide is particularly different having six replacements and a deletion of two residues.
Of the amino acid replacements occurring in owl monkey insulin, the conservative substitution of valine for isoleucine at A2 is particularly interesting as this is an invariant site in all insulins (1) as well as insulin-like growth factors I and II (6, 27, 28) . Of the other changes, B9 proline occurs in rat I and mouse I insulins, and A4 aspartic acid and A17 glutamine are present separately or together in a large number of insulins. Residue B27 is a highly variable site in the insulin B chain; however, alanine has not been previously reported at this position. Two of the five amino acid substitutions in owl monkey insulin (A4 aspartic acid and A17 glutamine) also occur in the guinea pig sequence (Fig. 3) . A third (B27) is a hydrophobic amino acid in both owl monkey and guinea pig insulin and an uncharged polar or basic residue in all other mammalian insulins.
Comparison ofthe biological and immunological properties of owl monkey and human insulins indicates that owl monkey insulin has only 20% of the potency and 1% of the immunoreactivity of human insulin. Computer-graphics model building of the owl monkey insulin sequence, kindly carried out by T. L. Blundell and his colleagues (Birkbeck College, University of London), based on the high-resolution porcine insulin structure (29) 
